Sinco Pharmaceutical Holdings (HKSE:06833) Inventory-to-Revenue : 0.04 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Sinco Pharmaceutical Holdings Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sinco Pharmaceutical Holdings's Average Total Inventories for the quarter that ended in Dec. 2023 was HK$64 Mil. Sinco Pharmaceutical Holdings's Revenue for the six months ended in Dec. 2023 was HK$1,586 Mil. Sinco Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.04.

Sinco Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2023 declined from Jun. 2023 (0.05) to Jun. 2023 (0.04)

A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sinco Pharmaceutical Holdings's Days Inventory for the six months ended in Dec. 2023 was 8.38.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sinco Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Dec. 2023 was 21.77.

Sinco Pharmaceutical Holdings Inventory-to-Revenue Historical Data

The historical data trend for Sinco Pharmaceutical Holdings's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinco Pharmaceutical Holdings Inventory-to-Revenue Chart

Sinco Pharmaceutical Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventory-to-Revenue

Get a 7-Day Free Trial

0.20

0.12

0.07

0.03

0.04

Sinco Pharmaceutical Holdings Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Inventory-to-Revenue	Get a 7-Day Free Trial														0.07	0.05	0.06	0.05	0.04

Competitive Comparison of Sinco Pharmaceutical Holdings's Inventory-to-Revenue

For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sinco Pharmaceutical Holdings's Inventory-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sinco Pharmaceutical Holdings's Inventory-to-Revenue falls into.

Sinco Pharmaceutical Holdings Inventory-to-Revenue Calculation

Sinco Pharmaceutical Holdings's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (A: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )
=	( (98.436	+	118.157)	/	2 )	/	2778.267
=	108.2965					/	2778.267
=	0.04

Sinco Pharmaceutical Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

	Inventory-to-Revenue (Q: Dec. 2023 )
=	Average Total Inventories					/	Revenue
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Revenue (Q: Dec. 2023 )
=	( (10.365	+	118.157)	/	2 )	/	1585.91
=	64.261					/	1585.91
=	0.04

Sinco Pharmaceutical Holdings (HKSE:06833) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sinco Pharmaceutical Holdings's Days Inventory for the six months ended in Dec. 2023 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2023 )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
	=	64.261	/	1399.165	*	365 / 2
	=	8.38

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sinco Pharmaceutical Holdings's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2023 )	/	Average Total Inventories (Q: Dec. 2023 )
	=	1399.165	/	64.261
	=	21.77

Sinco Pharmaceutical Holdings Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinco Pharmaceutical Holdings (HKSE:06833) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinco Pharmaceutical Holdings Ltd (HKSE:06833) » Definitions » Inventory-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN

Website

https://www.sinco-pharm.com

Sinco Pharmaceutical Holdings Ltd is an investment holding company engaged in the provision of comprehensive marketing, promotion, and channel management service for imported pharmaceutical products and medical devices in China. The company has three operating segments; the sale of imported pharmaceutical products segment, the research and manufacturing of aesthetic medicine segment, and the medical beauty services segment. Its product offering includes Human albumin solutions and Antibiotics like Axetine and Medocef.

Executives

Huang Zhijian	2305 Beneficiary of a trust
Fullwealth Holdings Limited	2201 Interest of corporation controlled by you
Risun Investments Limited	2101 Beneficial owner
Wickhams Cay Trust Company Limited	2301 Trustee
Huang Xiangbin	2307 Founder of a discretionary trust who can infl

Sinco Pharmaceutical Holdings (HKSE:06833) Headlines

No Headlines